CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (5)

Name (Synonyms) Correlation
drug148 Best Supportive Care Wiki 1.00
drug945 Ravulizumab Wiki 1.00
drug111 Azithromycin 500 mg Wiki 1.00
drug522 Hydroxychloroquine Sulfate Wiki 0.30
drug872 Placebos Wiki 0.25

Correlated MeSH Terms (7)

Name (Synonyms) Correlation
D055370 Lung Injury NIH 0.25
D011024 Pneumonia, Viral NIH 0.14
D013577 Syndrome NIH 0.13
D055371 Acute Lung Injury NIH 0.13
D012127 Respiratory Distress Syndrome, Newborn NIH 0.13
D012128 Respiratory Distress Syndrome, Adult NIH 0.11
D011014 Pneumonia NIH 0.07

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.07

There is one clinical trial.

Clinical Trials

1 Adjuvant Use of Ivermectin To Hydroxychloroquine and Azithromycin in Patients With Covid19: A Novel Double Blind Placebo Controlled Pilot Study

Comparing the efficacy and safety of adjuvant use of Ivermectin in covid19 patients with pneumonia using Ivermectin with hydroxychloroquine compared to HCQ

NCT04343092 COVID 19 Drug: Ivermectine Drug: Hydroxychloroquine Sulfate Drug: Placebos Drug: Azithromycin 500 mg

Primary Outcomes

Description: Number of patients cured assessed by Nasopharyngeal swab, oropharyngeal swab, and blood aspiration for covid19 (PCR) in addtion to Chest xary

Measure: Number of cured patients

Time: 2 weeks

Secondary Outcomes

Description: Adverse events are assessed by Complete blood count (CBC), Liver function tests (ALT, AST),Renal function tests (blood urea, serum creatinine) and Fasting blood sugar test

Measure: Number of participants with treatment-related adverse events

Time: 2 weeks

No related HPO nodes (Using clinical trials)